(1S,2S)- N,N'-Dimethyl-1,2-cyclohexanediamine - CAS 87583-89-9
Catalog: |
BB038534 |
Product Name: |
(1S,2S)- N,N'-Dimethyl-1,2-cyclohexanediamine |
CAS: |
87583-89-9 |
Synonyms: |
(1S,2S)-N1,N2-dimethylcyclohexane-1,2-diamine; (1S,2S)-1-N,2-N-dimethylcyclohexane-1,2-diamine |
IUPAC Name: | (1S,2S)-1-N,2-N-dimethylcyclohexane-1,2-diamine |
Description: | (1S,2S)- N,N'-Dimethyl-1,2-cyclohexanediamine (CAS# 87583-89-9) is a useful research chemical. |
Molecular Weight: | 142.24 |
Molecular Formula: | C8H18N2 |
Canonical SMILES: | CNC1CCCCC1NC |
InChI: | InChI=1S/C8H18N2/c1-9-7-5-3-4-6-8(7)10-2/h7-10H,3-6H2,1-2H3/t7-,8-/m0/s1 |
InChI Key: | JRHPOFJADXHYBR-YUMQZZPRSA-N |
Boiling Point: | 186.8 °C / 760 mmHg |
Melting Point: | 47 °C |
Flash Point: | 74 °C(165.2 °F) |
Purity: | ≥ 97 % |
Density: | 0.902 g/mL |
Solubility: | Slightly soluble in water. |
Appearance: | Powder or chunks |
Storage: | Sealed in dry. Inert atmosphere. Keep cold. |
MDL: | MFCD00671528 |
LogP: | 1.51820 |
GHS Hazard Statement: | H302 (95.56%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P260, P264, P270, P280, P301+P312, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P330, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113292620-A | Improved process for preparing clofarabine intermediate 3 ', 5' -di-O-benzoyl-2-chloroadenosine | 20210524 |
CN-113264945-A | Spiro derivative, preparation method and medical application thereof | 20200217 |
WO-2021155841-A1 | Heterocyclic glp-1 agonists | 20200207 |
WO-2021156787-A1 | Heterocyclic compounds as dihydroorotate dehydrogenase inhibitors | 20200204 |
US-2021230146-A1 | Thyroid hormone receptor agonists and use thereof | 20200113 |
PMID | Publication Date | Title | Journal |
19689116 | 20090917 | Synthesis of enol lactones via Cu(I)-catalyzed intramolecular O-vinylation of carboxylic acids | Organic letters |
Complexity: | 81.3 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 2 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 142.146998583 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 142.146998583 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 24.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
-
Catalog: BB053081
({1-[(1,5-Dimethyl-1H-Pyrazol-4-Yl)Methyl]Piperidin-3-Yl}Methyl)Amine Dihydrochloride
Detail
-
Catalog: BB043168
(+/-)-3-Amino-1,2,3,4-tetrahydroquinoline
Detail
-
Catalog: BB053726
(±)-Dihydrozeatin
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB018000
(+)-Bis[(R)-1-phenylethyl]amine
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB037960
(1,2,3,4-Tetrahydro-1-naphthyl)methanamine Oxalate
Detail
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[891016-02-7]
ML-SI3
-
[65039-10-3]
1-Allyl-3-methyl-3-imidazolium Chloride
-
[1041205-43-9]
1-(Difluoromethyl)-4-iodo-1H-pyrazole
INDUSTRY LEADERS TRUST OUR PRODUCTS